Glassman Wealth Services’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-114
Closed -$1.06K 1135
2023
Q4
$1.06K Hold
114
﹤0.01% 1528
2023
Q3
$1.45K Hold
114
﹤0.01% 1438
2023
Q2
$1.62K Hold
114
﹤0.01% 1315
2023
Q1
$1.7K Hold
114
﹤0.01% 1292
2022
Q4
$1.69K Sell
114
-65
-36% -$1.06K ﹤0.01% 1296
2022
Q3
$3K Buy
179
+65
+57% +$1.31K ﹤0.01% 1139
2022
Q2
$2K Hold
114
﹤0.01% 1255
2022
Q1
$3K Hold
114
﹤0.01% 1144
2021
Q4
$3K Hold
114
﹤0.01% 1114
2021
Q3
$3K Hold
114
﹤0.01% 1080
2021
Q2
$3K Hold
114
﹤0.01% 1066
2021
Q1
$3K Hold
114
﹤0.01% 1007
2020
Q4
$3K Hold
114
﹤0.01% 985
2020
Q3
$2K Hold
114
﹤0.01% 1017
2020
Q2
$2K Buy
114
+90
+375% +$1.33K ﹤0.01% 872
2020
Q1
$0 Sell
24
-28
-54% -$577 ﹤0.01% 1381
2019
Q4
$1K Buy
52
+25
+93% +$627 ﹤0.01% 972
2019
Q3
$1K Buy
27
+11
+69% +$251 ﹤0.01% 873
2019
Q2
$0 Sell
16
-2
-11% -$54 ﹤0.01% 1244
2019
Q1
$0 Buy
+18
New +$604 ﹤0.01% 1138
2018
Q2
Sell
-6
Closed 889
2018
Q1
$0 Hold
6
﹤0.01% 843
2017
Q4
$0 Buy
+6
New +$283 ﹤0.01% 738

Other funds holding MD

Glassman Wealth Services's MD Position: Q1 2024 in Review

Glassman Wealth Services sold out of Pediatrix Medical (MD) in Q1 2024, closing a stake of 114 shares — an estimated $1.06K sold.

Glassman Wealth Services first reported a position in MD in Q4 2017 and held it in 22 quarters. The position peaked at $3K in Q3 2022. 213 funds tracked by Wall St. Rank hold MD as of Q1 2024.

  • Glassman Wealth Services reported no remaining Pediatrix Medical position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 114 Pediatrix Medical shares in Q1 2024, an estimated $1.06K.
  • Glassman Wealth Services first reported a position in Pediatrix Medical in Q4 2017 and held it in 22 quarters.
  • Glassman Wealth Services's Pediatrix Medical position peaked at $3K in Q3 2022.
  • 213 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.